The management team of Simris Group is currently composed of Julian Read (CEO), Christoffer Tell, (CFO) and Hannes Hall (Head of Algae Farm).

Simris Group confirms that Dr Heike Enke, Chief Science Officer for non-ADC Technologies within Simris Biologics, will, as of 31st July, be appointed to the Group Management Team.

Dr Enke holds a PhD in Genetic Biology from Humboldt University in Berlin and is a co-founder of the company Cyano Biotech GmbH, acquired by Simris in August 2022. She has more than 20 years of experience in cyanobacterial strain development during which time she has built a collection of almost 1,200 strains of cyanobacteria. Dr Enke has performed extensive R&D optimising cyanobacteria for biofuel production and to identify novel, natural compounds for use in pharmaceuticals, cosmetics and agricultural products. She is also a co-inventor of Simris’ platform for the development of ADC-payloads from cyanobacterial toxins.

Dr Enke currently coordinates all Research & Development activities outside of Simris’ ADC-technology. In this capacity she leads cyanobacterial strain development activities and is tasked with the identification of new opportunities within the cyanobacteria/ microalgae space. This includes the research collaboration with Malmö University which evaluates compounds and extracts from cyanobacteria and microalgae for use within the cosmetic industry. Dr Enke is also responsible for the development and production of the cyanobacterial standards that Simris Biologics supplies to water authorities tasked with monitoring the presence of cyanobacterial toxins in public bodies of water.

Concurrent with this appointment Hannes Hall (head of Simris’ algae farm based in Hammenhög, Sweden), will step down from the Group Management Team.